Contrast Media pp 125-130 | Cite as

Contrast Media and Interactions with Other Drugs and Clinical Tests

  • Sameh K. Morcos
Part of the Medical Radiology book series (MEDRAD)


Water soluble contrast media may interfere with the pharmacokinetics or pharmacodynamics of other drugs, as well as with some biochemical assays and with isotope imaging. These topics are reviewed in this chapter, with the aim of raising the awareness of both radiologists and clinicians to the possibility of these problems.


Contrast Agent Contrast Medium Negative Inotropic Effect Contrast Media Injection Intravascular Administration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Abi-Aad AS, Figlin RA, Belldegrun A, de Kernion JB (1991) Metastatic renal cell cancer: Interleukin-2 toxicity induced by contrast agent injection. J Immun 10:292–295CrossRefGoogle Scholar
  2. Barrs TJ (2002) Establishing safeguards for the use of imaging related drugs. Am J Health Syst Pharm 59:1449–1553PubMedGoogle Scholar
  3. Choyke PL, Miller DL, Lotze MT et al (1992) Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 183:111–114PubMedGoogle Scholar
  4. Choyke PL, Knopp MV (2003) Pseudohypocalcemia with MR imaging contrast agents: a cautionary tale. Radiology 227:627–628PubMedCrossRefGoogle Scholar
  5. Crawford JA, Gumerman LW (1978) Alteration of body distribution of Tc99 m-pyrophosphate by radiographic contrast material. Clin Nucl Med 3:305–307PubMedCrossRefGoogle Scholar
  6. Dehmer GJ, Gresalfi N, Daly D et al (1995) Impairment of fibrinolysis by streptokinase, urokinase and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents. J Am Coll Cardiol 25:1069–1075PubMedCrossRefGoogle Scholar
  7. Fischer HW, Morris TW (1980) Possible factors in intravascular contrast media toxicity. Invest Radiol 15(Suppl 6): S232–S238Google Scholar
  8. Frohlich JM (2001) Systematic survey of interactions between contrast media and other drugs, Special edition by Guerbet SwitzerlandGoogle Scholar
  9. Greenberg PA, Myers SN, Kramer BL et al (1987) Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media. J Allergy Clin Immunol 80:698–702CrossRefGoogle Scholar
  10. Harned TM, Mascarenhas L (2007) Severe methotrexate toxicity precipitated by intravenous radiographic contrast. Clin Lab Observ 29:496–499Google Scholar
  11. Higgins CB, Kruber M, Slutsky RA (1983) Interaction between verapamil and contrast media in coronary arteriography: comparison of standard ionic and new nonionic media. Circulation 68:628–635PubMedCrossRefGoogle Scholar
  12. Kim SH, Lee HK, Han MC (1992) Incompatibility of water-soluble contrast media and intravascular pharmacologic agents. An in vitro study. Invest Radiol 27:45–49CrossRefGoogle Scholar
  13. Jakobsen JÅ, Oyen R, Thomsen HS, Morcos SK, members of Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR) (2005) Safety of ultrasound contrast media. Eur Radiol 15:941–945Google Scholar
  14. Junge W, Troge B (1991) Kontrastmittel als Störfaktoren in der laborchemischen analytik. In: Peters PE, Zetler E (eds) Röntgen Kontrastmittel. Springer, Berlin, pp 76–82Google Scholar
  15. Laurence DR, Bennett PN (1992) Clinical pharmacology, 7th edn. Churchill Livingstone, Edinburgh, pp 416–423Google Scholar
  16. Lang DM, Alpern MB, Visintainer PF, Smith ST (1991) Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med 115:270–276PubMedCrossRefGoogle Scholar
  17. Lang DM, Alpern MB, Visintainer PF, Smith ST (1993) Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure and cardiovascular disorders. Arch Intern Med 153:2033-2040. Erratum in Arch Intern Med 153:2412CrossRefGoogle Scholar
  18. Massee DR, Smith DC, Westengard JC, Bull BS (1991) Heparin supplementation of nonionic contrast agents. J Vasc Interv Radiol 2:209–213PubMedCrossRefGoogle Scholar
  19. Morcos SK (1998) Contrast media-induced nephrotoxicity-questions and answers. Br J Radiol 71:357–365PubMedGoogle Scholar
  20. Morcos SK, Dawson P, Pearson JD et al (1998) The hemodynamic effects of iodine-based water soluble radiographic contrast media: a review. Eur J Radiol 29:31–46PubMedCrossRefGoogle Scholar
  21. Morcos SK, El Nahas AM, Brown P, Haylor J (1992) Effect of iodinated water soluble contrast media on urinary protein assays. BMJ 305:29PubMedCrossRefGoogle Scholar
  22. Morcos SK, Thomsen HS, Webb JAW, ESUR Contrast Media Safety Committee (1999) Contrast media-induced nephrotoxicity: a consensus report. Eur Radiol 9:1602–1613Google Scholar
  23. Morcos SK, Thomsen HS, ESUR Contrast Media Safety Committee (2005). Contrast media: Interactions with other drugs and clinical tests. Eur Radiol 15:1607–1614Google Scholar
  24. Morris DL, Wisneski JA, Gertz EW et al (1985) Potentiation by nifedipine and diltiazem of the hypotensive response after contrast angiography. J Am Coll Cardiol 6:785–791PubMedCrossRefGoogle Scholar
  25. Normann PT, Frøysa A, Svaland M (1995) Interference of gadodiamide injection (OMNISCAN®) on the colorimetric determination of serum calcium. Scand J Clin Lab Invest 55:421–426PubMedCrossRefGoogle Scholar
  26. Parvez Z, Moncada R, Messmore HL, Fareed J (1982) Ionic and non-ionic contrast media interaction with anticoagulant drugs. Acta Radiol Diagn (Stockh) 23:401–404Google Scholar
  27. Pislaru S, Pislaru C, Szilard M et al (1998) In vivo effects of contrast media on coronary thrombolysis. J Am Coll Cardiol 32:1102–1108PubMedCrossRefGoogle Scholar
  28. Prince MR, Erel HE, Lent RW et al (2003) Gadodiamide administration causes spurious hypocalcemia. Radiology 227:639–646PubMedCrossRefGoogle Scholar
  29. Proctor KAS, Rao LV, Roberts WL (2004) Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays. Am J Clin Pathol 121:282–292PubMedCrossRefGoogle Scholar
  30. Reynolds N, Wallington TB, Burton JL (1993) Hydralazine predisposes to acute cutaneous vasculitis following urography with iopamidol. Br J Dermatol 129:82–85PubMedCrossRefGoogle Scholar
  31. Swanson DP, Chilton HM, Thrall JH (eds) (1990) Pharmaceuticals in medical imaging: radiopaque contrast media, radiopharmaceuticals, enhancement agents for magnetic resonance imaging and ultrasound. Macmillan. New York, Toronto, p 42Google Scholar
  32. Tatum JL, Burke TS, Hirsch JI et al (1983) Pitfall to modified in vivo method of technetium-99 m red blood cell labeling Iodinated contrast media. Clin Nucl Med 8:585–587PubMedCrossRefGoogle Scholar
  33. Thomsen HS, Morcos SK, ESUR Contrast Media Safety Committee (1999) Contrast media and metformin. Guidelines to diminish the risk of lactic acidosis in noninsulin dependent diabetics after administration of contrast media. Eur Radiol 9:738–740Google Scholar
  34. Thomsen HS, Morcos SK (2003) Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines. Br J Radiol 76:513–551PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Diagnostic ImagingUniversity of SheffieldSheffieldUK

Personalised recommendations